World

First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. 

TORRETORRE
Jan 5, 2026 - 18:00
 0
First GLP-1 pill for obesity from Novo Nordisk launches in the U.S. 
The drug's cash prices are among the lowest on the market, ranging from $149 to $299 per month, depending on the dose.
Read More
TORRE
TORRE

Related Posts

US demanding Venezuela cut ties with Russia and China – ABC

US demanding Venezuela cut ties with Russia and China –...

TORRE Jan 7, 2026  0

US planning to buy Greenland – WSJ

US planning to buy Greenland – WSJ

TORRE Jan 7, 2026  0

India’s state-owned refiners keep buying Russian oil even as New Delhi seeks U.S. tariff relief

India’s state-owned refiners keep buying Russian oil ev...

TORRE Jan 7, 2026  0

She immigrated to the U.S. and was sleeping in her car as a single mother–now, her candy company brings in over $9 million a year

She immigrated to the U.S. and was sleeping in her car ...

TORRE Jan 7, 2026  0

European markets head for mixed open as Greenland fears grow

European markets head for mixed open as Greenland fears...

TORRE Jan 7, 2026  0

At the U.N., Even Allies Condemn U.S. Action in Venezuela

At the U.N., Even Allies Condemn U.S. Action in Venezuela

TORRE Jan 7, 2026  0